The protective role of prosaposin and its receptors in the nervous system
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Prosaposin (also known as SGP-1) is an intriguing multifunctional protein that plays roles both intracellularly, as a regulator of lysosomal enzyme function, and extracellularly, as a secreted factor with neuroprotective and glioprotective effects. Following secretion, prosaposin can undergo endocytosis via an interaction with the low-density lipoprotein-related receptor 1 (LRP1). The ability of secreted prosaposin to promote protective effects in the nervous system is known to involve activation of G proteins, and the orphan G protein-coupled receptors GPR37 and GPR37L1 have recently been shown to mediate signaling induced by both prosaposin and a fragment of prosaposin known as prosaptide. In this review, we describe recent advances in our understanding of prosaposin, its receptors and their importance in the nervous system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129 · cited 1×
“Brain (Cahoy et al., 2008; Donohue et al., 1998; Imai et al., 2001; Leng et al., 1999; Marazziti et al., 1997, 1998; Valdenaire et al., 1998; Zeng et al., 1997).”
Neurotrophins and their receptors: A convergence point for many signalling pathways
Chao, M. V. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1078 · Cited by 2,298 · cited 1×
“One of the largest and most intensively-studied families of protective factors is the neurotrophins, which includes nerve growth factor, brain-derived neurotrophic factor and several other secreted proteins that act predominantly through receptor tyrosine kinases (Chao, 2003).”
BackgroundLysosomal Glycosphingolipid Recognition by NKT Cells
Zhou, D., Mattner, J., Cantu, C., Schrantz, N., Yin, N., Gao, Y., Sagiv, Y., Hudspeth, K., Wu, Y.-P., Yamashita, T., et al. (2004) · Science · doi:10.1126/science.1103440 · Cited by 956
GDNF, NGF and BDNF as Therapeutic Options for Neurodegeneration
Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., & Patel, N. K. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.004 · Cited by 820 · cited 1×
“Such protective factors and their receptors have garnered significant research interest for their potential as therapeutic targets in the treatment of neurological damage and disease (Allen et al., 2013; Schulte-Herbruggen et al., 2008).”
BackgroundLipoprotein receptors in the nervous system
Herz, J., & Bock, H. H. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135342 · Cited by 457 · cited 2×
“As mentioned earlier, LRP1 has numerous other substrates (Herz and Bock, 2002; Lillis et al., 2005), and therefore it may be challenging to achieve selective modulation of prosaposin levels by targeting LRP1.”
BackgroundSpiegel, R., Bach, G., Sury, V., Mengistu, G., Meidan, B., Shalev, S., Shneor, Y., Mandel, H., & Zeigler, M. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.10.004 · Cited by 129
Marzolo, M.-P., & Bu, G. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.10.005 · Cited by 122 · cited 1×
“…protein and regulator of cell surface receptors and proteases (Boucher et al., 2003; Deane et al., 2008; Herz et al., 1988; Loukinova et al., 2002; Marzolo and Bu, 2009), and in this capacity it has attracted attention due to its ability to influence β-amyloid production (Lillis et al., 2008;…”
BackgroundThe low-density lipoprotein receptor-related protein 1 in inflammation
May, P. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32835e809c · Cited by 49 · cited 1×
“In the brain, LRP1 expression has been identified in neurons and astrocytes (Lillis et al., 2008) as well as microglia (May, 2013).”
BackgroundDiaz-Font, A., Cormand, B., Santamaria, R., Vilageliu, L., Grinberg, D., & Chabás, A. (2005) · Human Genetics · doi:10.1007/s00439-005-1288-x · Cited by 48 · cited 1×
“Saposin D deficiency has also been reported in a patient diagnosed with Gaucher's disease (Diaz-Font et al., 2005).”
Background
Cited by
Screening cell–cell communication in spatial transcriptomics via collective optimal transport
(2023) · doi:10.1038/s41592-022-01728-4 · Cited by 484
GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain
Bang, S., Xie, Y.-K., Zhang, Z.-J., Wang, Z., Xu, Z.-Z., & Ji, R.-R. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99888 · Cited by 285
Progranulin, lysosomal regulation and neurodegenerative disease
Kao, A. W., McKay, A., Singh, P. P., Brunet, A., & Huang, E. J. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.36 · Cited by 258
Prosaposin is a regulator of progranulin levels and oligomerization
Nicholson, A. M., Finch, N. A., Almeida, M., Perkerson, R. B., van Blitterswijk, M., Wojtas, A., Cenik, B., Rotondo, S., Inskeep, V., Almasy, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms11992 · Cited by 91
Sharoar, M. G., Palko, S., Ge, Y., Saido, T. C., & Yan, R. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00464-1 · Cited by 78
“Abbreviations Aβ: β-amyloid; AD: Alzheimer’s disease; APP: Amyloid precursor proteins; ATG9A: Autophagy related protein 9A; DAB: 3,3′-Diaminobenzidine; DAM: Disease associated microglia; DNs: Dystrophic neurites; EEA1: Early endosome antigen 1; ER: Endoplasmic reticulum; FBS: Fetal bovine serum; FAD: Familial AD; Gal-…”
BackgroundInfluential
Metadata
- Authors
- Meyer, R. C., Giddens, M. M., Coleman, B. M., & Hall, R. A.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 1585
- Pages
- 1-12
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W1999736361
- Cited by
- 142
- References
- 9
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.